Biophytis SA logo
Biophytis SA BPTS

Annual report 2023
added 12-27-2025

report update icon

Biophytis SA Cash and Cash Equivalents 2011-2026 | BPTS

Annual Cash and Cash Equivalents Biophytis SA

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
5.57 M 11.1 M 23.9 M 5.85 M 6.34 M 14.4 M 19.9 M - - - - - -

All numbers in EUR currency

Indicator range from annual reports

Maximum Minimum Average
23.9 M 5.57 M 12.4 M

Quarterly Cash and Cash Equivalents Biophytis SA

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - - - 23.9 M - - - 5.85 M - - - 6.34 M - - - 14.4 M - - - 19.9 M - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in EUR currency

Indicator range from quarterly reporting

Maximum Minimum Average
23.9 M 5.85 M 14.1 M

Cash and Cash Equivalents of other stocks in the Biotechnology industry

Issuer Cash and Cash Equivalents Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
158 M - 2.43 % $ 254 M germanyGermany
Annovis Bio Annovis Bio
ANVS
5.75 M $ 2.52 1.2 % $ 22.7 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
30 M - -24.86 % $ 820 K usaUSA
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
34.8 M $ 3.56 3.79 % $ 8.57 B australiaAustralia
Actinium Pharmaceuticals Actinium Pharmaceuticals
ATNM
72.9 M $ 1.21 0.74 % $ 36.4 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
240 M $ 1.62 7.28 % $ 413 M britainBritain
Axsome Therapeutics Axsome Therapeutics
AXSM
323 M $ 162.88 0.34 % $ 8.1 B usaUSA
Aytu BioScience Aytu BioScience
AYTU
31 M $ 2.58 2.38 % $ 16.2 M usaUSA
I-Mab I-Mab
IMAB
4.76 B - - $ 866 M chinaChina
BridgeBio Pharma BridgeBio Pharma
BBIO
570 M $ 64.71 -0.99 % $ 12.4 B usaUSA
Bicycle Therapeutics plc Bicycle Therapeutics plc
BCYC
880 M $ 5.32 2.31 % $ 310 M britainBritain
Atara Biotherapeutics Atara Biotherapeutics
ATRA
25 M $ 7.11 37.52 % $ 53.2 M usaUSA
Beam Therapeutics Beam Therapeutics
BEAM
295 M $ 26.95 1.53 % $ 2.67 B usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
85.7 M - - $ 1.01 B usaUSA
Biohaven Pharmaceutical Holding Company Ltd. Biohaven Pharmaceutical Holding Company Ltd.
BHVN
172 M $ 9.66 -2.62 % $ 625 M usaUSA
Biogen Biogen
BIIB
3.01 B $ 184.68 -0.1 % $ 27.1 B usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
1.67 M - -18.52 % $ 27.3 M britainBritain
BioVie BioVie
BIVI
17.5 M $ 1.34 -1.47 % $ 1.98 M usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
13.4 M - - $ 2.17 B usaUSA
AlloVir AlloVir
ALVR
118 M - 4.14 % $ 49.1 M usaUSA
BioLineRx Ltd. BioLineRx Ltd.
BLRX
10.4 M $ 2.65 - $ 908 M israelIsrael
BioMarin Pharmaceutical BioMarin Pharmaceutical
BMRN
1.31 B $ 60.17 -1.55 % $ 11.5 B usaUSA
Bristol-Myers Squibb Company Bristol-Myers Squibb Company
BMY
10.2 B $ 60.1 -0.32 % $ 122 B usaUSA
Benitec Biopharma Benitec Biopharma
BNTC
97.7 M $ 12.76 12.52 % $ 525 M usaUSA
BioNTech SE BioNTech SE
BNTX
9.76 B $ 100.99 -0.51 % $ 27.2 B germanyGermany
Adverum Biotechnologies Adverum Biotechnologies
ADVM
60.7 M - - $ 86.2 M usaUSA
ADC Therapeutics SA ADC Therapeutics SA
ADCT
326 M $ 4.07 -0.73 % $ 105 M schweizSchweiz
Acer Therapeutics Acer Therapeutics
ACER
2.33 M - 2.71 % $ 14 M usaUSA
ARCA biopharma ARCA biopharma
ABIO
61.6 M - 1052.0 % $ 415 M usaUSA
BioXcel Therapeutics BioXcel Therapeutics
BTAI
29.9 M $ 1.72 16.22 % $ 4.36 M usaUSA
Burford Capital Limited Burford Capital Limited
BUR
322 M $ 8.05 3.67 % $ 1.31 B britainBritain
Aeterna Zentaris Aeterna Zentaris
AEZS
16.4 M - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
345 K - -10.17 % $ 12.2 K usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
46.4 M - - $ 26.5 M usaUSA
BeyondSpring BeyondSpring
BYSI
110 M $ 1.45 - $ 58.5 M usaUSA
Cabaletta Bio Cabaletta Bio
CABA
193 M $ 3.18 0.42 % $ 3.71 M usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
340 M - - $ 3.67 B usaUSA
Akouos Akouos
AKUS
122 M - 0.23 % $ 488 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
8.27 M $ 3.93 -13.63 % $ 8.55 B israelIsrael
Capricor Therapeutics Capricor Therapeutics
CAPR
14.7 M $ 29.47 5.61 % $ 789 M usaUSA
Acasti Pharma Acasti Pharma
ACST
22.1 M - 4.01 % $ 150 M canadaCanada
Catalyst Biosciences Catalyst Biosciences
CBIO
33.5 M $ 11.83 -2.03 % $ 779 M usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
4.09 M - -11.43 % $ 502 K usaUSA
C4 Therapeutics C4 Therapeutics
CCCC
74.6 M $ 3.62 18.91 % $ 300 M usaUSA
Codexis Codexis
CDXS
19.3 M $ 1.23 -0.41 % $ 90.3 M usaUSA
Cerus Corporation Cerus Corporation
CERS
20 M $ 1.86 -3.89 % $ 355 M usaUSA